VICTOR is a randomized, double-blind, placebo-controlled, multicenter, 2-part study to
evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and antiviral effect
of single and multiple dosing of AK0529 in infants hospitalized with RSV infection.